Marksans Pharma Limited, based out of India, is recalling their 500 mg and 750 mg metformin tablets sold under the brand name Time-Cap Labs, Inc. The recalled medication was found to contain dangerous levels of the suspected cancer-causing human carcinogen N-Nitrosodimethylamine (NDMA). These types of medications are used to treat type 2 diabetes and help lower glucose levels.
Recalled Products:
Metformin Hydrochloride Extended-Release Tablets, USP 500mg:
90 counts: 49483-623-09
100 counts: 49483-623-01
500 counts: 49483-623-50
1000 counts: 49483-623-10
Metformin Hydrochloride Extended-Release Tablets, USP 750mg:
100 counts: 49483-624-01
The National Drug Codes for the recalled products are posted above, and they can also be identified by the numbers on the actual tablets, 101 or 102. In a not totally surprising move, Marksans Pharma did not reveal the NDMA levels in their medications that forced the recall. 96 nanograms is the daily limit of N-Nitrosodimethylamine. The limit is this low for a reason. NDMA is classified by the U.S. Food and Drug Administration as a “probable human carcinogen”.
To read the full story over at CNN.com, follow this link: https://cnn.it/2GOXuM7
